Search Results - "Saif, M Wasif"

Refine Results
  1. 1

    Pharmacokinetically Guided Dose Adjustment of 5-Fluorouracil: A Rational Approach to Improving Therapeutic Outcomes by Saif, M. Wasif, Choma, Adrienne, Salamone, Salvatore J., Chu, Edward

    “…Chemotherapy dosing of the fluoropyrimidine 5-fluorouracil (5-FU) is currently based on body surface area. However, body surface area–based dosing has been…”
    Get full text
    Journal Article
  2. 2
  3. 3

    The Role of Src in Colon Cancer and Its Therapeutic Implications by Chen, Jiezhong, Elfiky, Aymen, Han, Mei, Chen, Chen, Saif, M. Wasif

    Published in Clinical colorectal cancer (01-03-2014)
    “…Abstract Src is a member of a superfamily of membrane-associated nonreceptor protein tyrosine kinases. It is stimulated by receptors of growth hormone,…”
    Get full text
    Journal Article
  4. 4

    The role of mTOR in the management of solid tumors: An overview by Strimpakos, Alex S, Karapanagiotou, Eleni M, Saif, M. Wasif, Syrigos, Kostas N

    Published in Cancer treatment reviews (01-04-2009)
    “…Summary Mammalian target of rapamycin (mTOR) is a key protein kinase controlling signal transduction from various growth factors and upstream proteins to the…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Small cell carcinoma of the colon arising in a carcinoid tumor by Saif, M Wasif

    Published in Anticancer research (01-04-2013)
    “…Small cell carcinomas of the gastrointestinal tract are rare and clinically aggressive tumors. A case is presented of a 70 year-old woman who presented with…”
    Get full text
    Journal Article
  7. 7

    Adenocarcinoma ex goblet cell carcinoid in a renal transplant patient: a case report and review of the literature by Saif, M Wasif

    Published in Anticancer research (01-04-2013)
    “…Adenocarcinoma ex goblet cell carcinoid is a rare neoplasm of appendiceal origin that contains features of both carcinoid tumor and adenocarcinoma. We report…”
    Get full text
    Journal Article
  8. 8

    Gastric cancer and trastuzumab: first biologic therapy in gastric cancer by Gunturu, Krishna S., Woo, Yanghee, Beaubier, Nike, Remotti, Helen E., Saif, M. Wasif

    Published in Therapeutic Advances in Medical Oncology (01-03-2013)
    “…Gastric cancer remains difficult to cure and has a poor overall prognosis. Chemotherapy and multimodality therapy has shown some benefit in the treatment of…”
    Get full text
    Book Review Journal Article
  9. 9

    Phase I/II Study of PHY906/Capecitabine in Advanced Hepatocellular Carcinoma by Yen, Yun, So, Samuel, Rose, Michal, Saif, M Wasif, Chu, Edward, Liu, Shwu-Huey, Foo, Angeline, Jiang, Zaoli, Su, Tahmun, Cheng, Yung-Chi

    Published in Anticancer research (01-10-2009)
    “…PHY906 is a Chinese medicine formula with claims for the treatment of severe gastrointestinal distress. PHY906 enhanced the therapeutic index of various…”
    Get full text
    Journal Article
  10. 10

    Does erlotinib restore chemosensitivity to chemotherapy in pancreatic cancer? A case series by Saif, M Wasif

    Published in Anticancer research (01-03-2011)
    “…Erlotinib (Tarceva) in combination with gemcitabine is indicated for first-line treatment of patients with locally advanced, unresectable or metastatic…”
    Get full text
    Journal Article
  11. 11

    Phase II study of intravenous TZT‐1027 in patients with advanced or metastatic soft‐tissue sarcomas with prior exposure to anthracycline‐based chemotherapy by Patel, Shreyaskumar, Keohan, Mary Louise, Saif, M. Wasif, Rushing, Daniel, Baez, Luis, Feit, Kevie, DeJager, Robert, Anderson, Sibyl

    Published in Cancer (15-12-2006)
    “…BACKGROUND. TZT‐1027, a novel chemotherapeutic agent, is derived from dolastatin 10, and blocks cells during G2/M‐phase by interfering with microtubule…”
    Get full text
    Journal Article
  12. 12
  13. 13

    Secondary pancreatic involvement by a diffuse large B-cell lymphoma presenting as acute pancreatitis by Saif, M-Wasif, Khubchandani, Sapna, Walczak, Marek

    Published in World journal of gastroenterology : WJG (28-09-2007)
    “…Diffuse large B-cell lymphoma is the most common type of non-Hodgkin's lymphoma. More than 50% of patients have some site of extra-nodal involvement at…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Phase I Study of Capecitabine With Concomitant Radiotherapy for Patients With Locally Advanced Pancreatic Cancer: Expression Analysis of Genes Related to Outcome by WASIF SAIF, M, ELOUBEIDI, Mohammaed A, RUSSO, Suzanne, STEG, Adam, THORNTON, Jennifer, FIVEASH, John, CARPENTER, Mark, BLANQUICETT, Carmello, DIASIO, Robert B, JOHNSON, Martin R

    Published in Journal of clinical oncology (01-12-2005)
    “…To establish the feasibility of capecitabine with concurrent radiotherapy (XRT) in patients with locally advanced (LA) pancreatic cancer and evaluate the…”
    Get full text
    Journal Article Conference Proceeding
  16. 16

    Primary Peritoneal Carcinoma in Complete Remission: a Case Report by RAMOS, Jorge, GUNTURU, Krishna S, KRISHNAMOORTHY, Saravanan, KENNEL, Barton, WASIF SAIF, M

    Published in Anticancer research (01-12-2011)
    “…Primary peritoneal carcinoma (PPCa) is a relatively uncommonly diagnosed tumor. It has a similar presentation to ovarian cancer. PPCa has a poor prognosis with…”
    Get full text
    Journal Article
  17. 17

    Bolus 5-Fluorouracil as an Alternative Modality to Infusion 5-Fluorouracil in a Patient with Rectal Cancer and Capecitabine-induced Cardiotoxicity by Shaib, Walid, Lee, Veronica, Saif, M Wasif

    Published in In vivo (Athens) (01-09-2009)
    “…5-Fluorouracil (5-FU) is the backbone of the chemotherapy regimens approved for treatment of colorectal cancer. Incidence of cardiotoxicity associated with…”
    Get full text
    Journal Article
  18. 18

    Erlotinib: the first biologic in the management of pancreatic cancer by Saif, M Wasif

    Published in Expert opinion on pharmacotherapy (01-06-2008)
    “…Pancreatic cancer remains a major therapeutic challenge largely characterized by chemotherapy-refractory disease and poor responses to currently available…”
    Get more information
    Journal Article
  19. 19

    Safety and Efficacy of Everolimus in Adult Patients with Neuroendocrine Tumors by Oberstein, Paul E., Saif, M. Wasif

    Published in Clinical Medicine Insights. Oncology (01-01-2012)
    “…Neuroendocrine tumors (NETs) consist of a diverse family of tumors which are derived from the neuroendocrine system. Most NETs are well or moderately…”
    Get full text
    Journal Article Book Review
  20. 20

    An Adverse Interaction Between Warfarin and Fluoropyrimidines Revisited by Saif, M. Wasif

    Published in Clinical colorectal cancer (01-09-2005)
    “…Regimens based on flouropyrimidines (eg, 5-fluorouracil [5-FU] and capecitabine) are the mainstay of chemotherapy for several malignancies, including colon,…”
    Get full text
    Journal Article